We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels
Product News

TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels

TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels
Product News

TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "TATAA Biocenter Expands Offerings using Roche´s RealTime ready Custom qPCR Assays and Panels"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

TATAA Biocenter is expanding its offerings to high-throughput gene expression profiling using Roche´s RealTime ready Custom qPCR Assays and Panels.

TATAA Biocenter's laboratories provide contract research for a full range of real-time qPCR services, including primer and probe design, validation, data analysis, and kit and instrument evaluation to pharmaceutical and biotech companies.

The company offers a seamless workflow, with all the instrumentation necessary for performing high quality experiments and for optimal sample handling, meeting the specific requirements for compliance with ISO17025 standard. TATAA laboratories are also available for academic researchers.

“The number of genes researchers characterize in a given sample is steadily increasing. In response to this demand, we now offer high-throughput profiling services in a complete workflow from nucleic acid extraction, gene profiling, and data mining,” reported Dr. Mikael Kubista, founder and CEO of TATAA Biocenter.

Dr. Kubista continued, “After extensive testing and validation of the various offerings on the market, we selected the Roche RealTime ready platform for its excellent performance combined with a workflow with exceedingly user-friendly wizard-based data mining with GenEx from MultiD Analysis”.

Advertisement